Mercury Laboratories Limited (BSE: 538964)
Health Care · Pharmaceuticals · IN
Rs770.00
+2.94% today · -12.4% 1Y
Mercury Laboratories Limited (BSE: 538964) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.54M.
Over the last twelve months the share price has lost 12.4%, trading between 620.55 and 942.90.
Tweenvest scores Mercury Laboratories Limited across four factors: quality 78/100, value 41/100, growth 6/100, dividend 26/100. Its strongest factor is quality.
538964 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.54M
- Revenue (TTM)
- $7.80M
- P/E
- 22.19
- EPS
- 34.70
- Dividend yield
- 0.45%
- Beta (5Y)
- 0.41
- 52-week high
- Rs942.90
- 52-week low
- Rs620.55
- Avg volume (3M)
- —
- Shares outstanding
- 1.20M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Y.B Urban Renewal - Residential Development LtdTASE: YBRD | $9.70M | ₪6.15 | +8.43% |
| Rapid Dose Therapeutics Corp.CNSX: DOSE | $9.66M | CA$0.10 | -16.67% |
| Concord Drugs LimitedBSE: 538965 | $9.58M | Rs70.40 | -7.00% |
| Active Fine Chemicals LimitedDSE: ACTIVEFINE | $9.55M | Tk4.90 | -10.91% |
| S.C. Sintofarm S.A.BVB: SINT | $9.37M | RON— | — |
| Marinomed Biotech AGWBAG: MARI | $9.11M | €— | — |
| InMed Pharmaceuticals Inc.NasdaqCM: INM | $9.04M | $1.36 | +2.26% |
| PEPTONIC medical AB (publ)XSAT: PMED | $8.90M | Skr0.00 | — |
Figures last refreshed Oct 11, 2026.